Evoke (EVOK) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
27 Nov, 2025Opening remarks and agenda
Meeting opened with a welcome and instructions for online participation and Q&A submission.
Chairman introduced board members, executive directors, and auditors present.
Voting procedures and shareholder rights were outlined, including proxy voting and poll process.
Notice of Meeting and resolutions 1 to 17 were referenced as the formal agenda.
Board and executive committee updates
Susan Stanley-Ford was welcomed as an independent non-executive director and member of the Audit and Risk Committee.
Susan will chair the newly formed Technology Committee, joined by Limor Ganot and Ori Shaked.
The Technology Committee will focus on governance and future industry insights.
Financial performance review
Business transformation since the previous AGM was described as extensive, with a refreshed strategy for value creation.
Revenue growth returned in the second half of last year and continued into 2025.
Asset sales were completed as part of business redevelopment, with no further sales planned at this time.
Latest events from Evoke
- Stable revenue and strong UK online growth offset higher duties and rising leverage risks.EVOK
H1 2026 - AGM focused on acquisition plans, improved 2025 results, and responses to UK regulatory changes.EVOK
AGM 2026 - Revenue and EBITDA rose, margins improved, and leverage fell amid strategic review and UK duty headwinds.EVOK
H2 2025 - FY25 revenue up 2%, EBITDA up 14-15%, with a strategic review amid UK tax hikes.EVOK
Q4 2025 TU - Revenue up 5% in Q3 2025, all divisions grew, and FY25 EBITDA margin guidance reaffirmed.EVOK
Q3 2025 TU - Strong revenue and EBITDA growth, improved margins, and significant deleveraging achieved.EVOK
H1 2025 - Revenue down, losses widen, but transformation and H2 margin recovery on track.EVOK
H1 2024 - H2 revenue growth of 5-9% and margin recovery expected, driven by cost savings and innovation.EVOK
Trading Update - Growth resumed in 2024 with rising margins, strong core markets, and a clear deleveraging plan.EVOK
H2 2024